Marjorie Pick

Title: Marjorie Pick: Innovator in Hematopoietic Cell Differentiation

Introduction

Marjorie Pick is a distinguished inventor based in Victoria, Australia. She has made significant contributions to the field of biomedical research, particularly in the area of hematopoietic cell differentiation. Her innovative work has led to the development of a unique peptide that has potential applications in medical treatments.

Latest Patents

Marjorie Pick holds a patent for her invention titled "Acetylcholinesterase (ACHE)-derived peptide as an inducer of granulocytopoiesis, uses and methods thereof." This patent describes the use of an AChE-R-derived peptide, also known as ARP, as an inducer of hemopoietic cell differentiation and expansion, specifically targeting the granulocytic population. The invention also highlights the use of ARP in inducing thrombopoietin and pro-inflammatory cytokines. Furthermore, ARP may be utilized in the pre-transplant priming of hematopoietic stem cells, showcasing its versatility in medical applications.

Career Highlights

Throughout her career, Marjorie has worked with notable organizations, including Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. and the Medical Research Fund at the Tel-Aviv Sourasky Medical Center. Her work in these institutions has allowed her to advance her research and collaborate with other experts in the field.

Collaborations

Marjorie has collaborated with esteemed colleagues such as Hermona Soreq and Dan Grisaru. These partnerships have contributed to her innovative research and the successful development of her patented technologies.

Conclusion

Marjorie Pick is a pioneering inventor whose work in hematopoietic cell differentiation has the potential to impact medical treatments significantly. Her contributions to the field are marked by her innovative patent and collaborations with leading researchers.